The AAMA Installs Jane B. Seelig, CMA-a (AAMA), as 2025-2027 Speaker of the House

November 17, 2025 6:00 PM

The American Association of Medical Assistants® (AAMA) installed Jane B. Seelig, CMA-A (AAMA), as the 2025-2027 AAMA Speaker of the House in Arlington, Virginia, at the 69th AAMA Annual Conference. In this capacity, Seelig, a resident of Columbus, Indiana, represents medical assistants and CMAs (AAMA)® across the nation."It is very rewarding to be elected to this leadership position by my peers," says Seelig. "My desire is to inspire others to...

Read more

The AAMA Installs Aimee Quinn, BHA, CMA (AAMA), as Vice Speaker of the House

November 17, 2025 6:00 PM

The American Association of Medical Assistants® (AAMA) installed Aimee Quinn, BHA, CMA (AAMA), as the 2025-2027 AAMA Vice Speaker of the House in Arlington, Virginia, at the 69th AAMA Annual Conference. In this capacity, Quinn, a resident of Coldwater, Ohio, represents medical assistants and CMAs (AAMA)® across the nation."Serving on the Board [of Trustees] these past two years has been such a rewarding journey - filled with learning, growth and...

Read more

The AAMA Installs Sherry Bogar, CN-BC, CMA (AAMA), as Vice President

November 17, 2025 6:00 PM

The American Association of Medical Assistants® (AAMA) installed Sherry Bogar, CN-BC, CMA (AAMA), as the 2025-2026 AAMA Vice President in Arlington, Virginia, at the 69th AAMA Annual Conference. In this capacity, Bogar, a resident of League City, Texas, represents medical assistants and CMAs (AAMA)® across the nation."Medical assistants are an essential and integral part of the health care team. Our education, knowledge and specialized training...

Read more

The AAMA Installs Christa Smith, CMA (AAMA), as 2025-2027 Trustee

November 17, 2025 6:00 PM

The American Association of Medical Assistants® (AAMA) installed Christa Smith, CMA (AAMA), as the 2025-2027 AAMA Trustee in Arlington, Virginia, at the 69th AAMA Annual Conference. In this capacity, Smith, a resident of Richland, Michigan, represents medical assistants and CMAs(AAMA)® across the nation."I am excited to start this new chapter with the AAMA and show all health care organizations the value of a credentialed medical assistant,"...

Read more

MEDHOST Announces General Availability of Enterprise and EDIS 2024 R1 Releases: Advancing Healthcare Interoperability

November 17, 2025 4:40 PM

MEDHOST, a leading EHR and healthcare IT solutions provider, has announced the general availability of its Enterprise 2024 R1 and EDIS 2024 R1 releases, along with the MEDHOST Health Data, Technology, and Interoperability - 1 (HTI-1) Solution. Together, these offerings form a comprehensive suite of integrated solutions designed to advance interoperability, compliance, and workflow optimization across healthcare enterprises and emergency...

Read more

Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value

November 17, 2025 3:40 PM

Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it has completed the initial stage of a strategic realignment by acquiring a controlling interest in LAMY, an SEC-reporting company (OTCID:LMMY), in exchange for Exousia Pro's subsidiary, Exousia AI, Inc., in an all-stock transaction. Exousia Pro received approximately 51% of LMMY restricted Common Stock,...

Read more

Darrel Kalinski Calls for Greater Awareness Around Mental and Emotional Health in Healthcare Workers

November 17, 2025 3:30 PM

After more than two decades of serving others - from military hospitals to operating rooms - Darrel Kalinski, a Certified Registered Nurse Anesthetist (CRNA) and former U.S. Navy Lieutenant, is speaking out about an issue that affects thousands of professionals every day: the emotional and mental wellbeing of healthcare workers.Kalinski, whose career was recently profiled in the feature "Darrel Kalinski: Service, Strength, and the Science of...

Read more

D.C. Circuit Grills DEA Over Years Long Delays as MMJ BioPharma Cultivation Demands Timely Ruling on Cannabis Grow

November 17, 2025 1:45 PM

A recent hearing in the U.S. Court of Appeals for the D.C. Circuit has put a harsh spotlight on the Drug Enforcement Administration's chronic delays in handling applications involving Schedule I substances-delays that mirror the seven-year limbo faced by MMJ BioPharma Cultivation, Inc., a subsidiary of MMJ International Holdings, Inc. On Friday, a three judge D.C. Circuit panel hearing In re Iowaska Church of Healing, appellate case No. 25-1140...

Read more

Reason Health Launches ReasonHub to Unlock the Value of Healthcare Knowledge Content

November 17, 2025 11:00 AM

Reason Health, the product unit of Vermonster, announces the beta launch of ReasonHub, the first purpose-built platform for healthcare knowledge. ReasonHub makes it easy to manage and publish digital quality measures, prior authorization rules, clinical guidelines, and other content that healthcare organizations need to create and share. Built on an enterprise-grade private FHIR® registry with full-featured terminology services and advanced AI...

Read more

Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie "Nurse Juhlzie" Monteiro with Community Celebrations December 13-14, 2025

November 17, 2025 9:10 AM

Compassion Center, the local Las Vegas community, and close friends and family will honor the life and immeasurable legacy of Julie "Nurse Juhlzie" Monteiro-our own living light, humanitarian, global community steward, loving mother, and loving wife-on December 13th and 14th, 2025, across multiple community venues in Las Vegas, NV, and beyond. Before continuing, the Creel, Monteiro, Solovieff, and Rackley families would like to all collectively...

Read more

VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

November 17, 2025 9:00 AM

VSee Health, Inc. (Nasdaq:VSEE), a pioneering provider of AI-powered telehealth solutions and high-acuity virtual care services, today announced its financial results for the third quarter ended September 30, 2025, as detailed in its Form 10-Q filed with the SEC on November 14, 2025.In Q3 2025, VSee achieved total revenues of $3.98 million, a 19% increase from $3.35 million in the prior-year period, fueled by heightened demand for its integrated...

Read more

Dr. Shajira Mohammed Joins Ankle & Foot Centers of America, Serving Emory Midtown and Lithonia Offices

November 17, 2025 9:00 AM

Ankle & Foot Centers of America is pleased to welcome Dr. Shajira Mohammed, a Georgia native and skilled podiatric physician, to its growing network of providers. Dr. Mohammed will serve patients at the Emory/ Midtown and Lithonia locations, expanding access to high-quality, patient-centered foot and ankle care in both urban and suburban areas.Dr. Mohammed earned her undergraduate degree as a Presidential Leadership Scholar from the University...

Read more

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

November 17, 2025 8:35 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the third quarter ended September 30, 2025 and provided a corporate update."As we head into the final quarter of the year, our mission remains centered on delivering meaningful...

Read more

Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump

November 17, 2025 8:30 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market with user-friendly, affordable patch pumps, today announced Institutional Review Board ("IRB") approval to conduct an in-house study of its next-generation Pivot™ insulin delivery system using insulin on people with diabetes (the "Study"). Pursuant to U.S....

Read more

NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position

November 17, 2025 8:30 AM

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange Commission (SEC) on Friday, November 14, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000110465925112608/nnvc-20250930x10q.htm).Clinical Stage NV-387, a Single Drug, Meets Many Unmet Medical Needs...

Read more

Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs

November 17, 2025 8:05 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC)("Ensysce" or the "Company"), pioneering novel solutions for severe pain with built-in abuse and overdose protection, today announced the closing of a $4 million convertible preferred stock financing, with upside to potentially $16 million of additional funding available through future tranches over the next 24 months.The capital will accelerate the Phase 3 clinical program for PF614, Ensysce's flagship...

Read more

Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue

November 17, 2025 8:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated third-quarter 2025 financial results.2025 THIRD QUARTER COMPANY FINANCIAL RESULTS:Net Revenue: The combined net revenue for the Company's prescription products (Mytesi®, Gelclair®, and Canalevia®-CA1), including license revenue, was approximately $3.1 million in the third quarter of 2025, representing an increase of approximately 4% over the combined...

Read more

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

November 17, 2025 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that it has submitted an FDA Commissioner's national priority voucher (CNPV) application on behalf of Skinject (SKNJCT-003) evaluating Doxorubicin Microneedle Array (D-MNA) to non-invasively treat basal cell carcinoma...

Read more

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

November 17, 2025 7:00 AM

OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology.Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the...

Read more

Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025

November 17, 2025 6:00 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20,...

Read more